Skip to main content

Automate the T-SPOT.TB Workflow

Automation solutions for every lab size

The T-SPOT.TB test can now be automated allowing for increased workflow efficiency and optimized hands-on time for latent tuberculosis testing. With our range of solutions, you can select the most cost-effective combination for your specific needs.

The T-SPOT.TB test enables accurate TB testing1 and when paired with our automation solutions you get efficient laboratory workflows without compromising on clinical performance.2 This powerful combination not only simplifies T-SPOT.TB testing but also provides confidence in the result.
 

img-t-spot-tb-hero-1.jpg

Choose your perfect level of automation

Only one single primary blood tube is needed throughout the T-SPOT.TB workflow

Extraction to analysis: Metagenomics workflows: 16 sequencing, WGS, and metatranscriptomics
Extraction to analysis: Metagenomics workflows: 16 sequencing, WGS, and metatranscriptomics

* Pipetting steps can be easily performed manually or automated for a more efficient workflow

** Each result should be individually validated before reporting

infection-disease-hero1077x606

Investigator Led Studies at Revvity

We are committed to improving the care of patients with immune-regulated conditions by providing funding and other forms of support to qualified investigators who share our commitment and work within our areas of interest.

Reference

  1. Oxford Immunotec. T-SPOT.TB Package Insert PI-TB-IVD-UK-V7. Abingdon, UK. September 2024. Oxford Immunotec. T-SPOT.TB Package Insert PI-TB-US-0001 v14. Abingdon, UK. November 2023
  2. T-Cell Select Package Insert PI-TS-IVD-UK-V9 Abingdon, UK. September 2024. T-Cell Select Package Insert PI-TS-IVD-US v6. Abingdon, UK. March 2025.
  3. Rego K, et al. Utility of the T-SPOT®.TB test’s borderline category to increase test resolution for results around the cut-off point. Tuberculosis. 2018;108:178
  4. Wong SH, Gao Q, Tsoi KK, Wu WK, Tam LS, Lee N, Chan FK, Wu JC, Sung JJ, Ng SC. Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis. Thorax. 2016 Jan
  5. Clark SA, Martin SL, Pozniak A, et al. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol. 2007;150(2):238-244.

*Mid run user intervention with Auto-Pure 2400 workflow with Cellaca MX
**In immunosuppressed individuals two tubes may be requested

T-SPOT.TB, Auto-Pure 2400, 24, 20B and 10B: For in vitro diagnostic use.

Cellaca MX & Microwell Imager: For Research Use Only. Not for use in diagnostic procedures.

Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.

Copyright ©2025, Revvity, Inc. All rights reserved. Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.

Questions?
We’re here to help.

Contact us